IFN-alpha 1 Antibody [HRP] - (Research Grade rontalizumab Biosimilar)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28270H
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Concentration
Product Specifications
Immunogen
Clonality
Host
Isotype
Applications for IFN-alpha 1 Antibody [HRP] - (Research Grade rontalizumab Biosimilar)
ELISA
Flow Cytometry
Functional
Formulation, Preparation, and Storage
Purification
Formulation
Preservative
Concentration
Shipping
Stability & Storage
Background: IFN-alpha 1
Interferon-alpha (IFN-alpha), also known as leukocyte interferon, represents a group of related but distinct proteins that share over 95% amino acid sequence homology. They are members of the type I interferon family which share a common cell surface receptor composed of two subunits, a 100 kDa ligand-binding subunit (IFN-alpha R2) and a 125 kDa ligand binding and signal transduction subunit (IFN-alpha R1) that is involved both in ligand binding and signal transduction. IFN-alpha has both anti-viral and immunomodulatory activities on target cells.
Long Name
Alternate Names
Gene Symbol
Additional IFN-alpha 1 Products
Product Documents for IFN-alpha 1 Antibody [HRP] - (Research Grade rontalizumab Biosimilar)
Product Specific Notices for IFN-alpha 1 Antibody [HRP] - (Research Grade rontalizumab Biosimilar)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.